Music Industry Lawsuit

Business

Digistar Corp's Turnaround Gains Traction: Improved Capital Efficiency Sparks Investor Interest

After years of lackluster performance, Digistar Corporation Berhad (KLSE:DIGISTA) is showing early signs of a operational turnaround, marked by a notable improvement in its return on capital employed. While still trailing the industry average, the shift from losses to profitability on a reduced capital base offers a glimmer of hope for the battered stock.

Jan 30, 2026

Business

U.S. Bets on Rare Earths Diversity with $1.6 Billion Rival Backing, MP Materials Navigates New Policy Landscape

The U.S. government's $1.6 billion commitment to USA Rare Earth signals a strategic pivot towards fostering competition in the critical minerals sector, reducing price supports and introducing new volatility. As policy shifts, industry leader MP Materials counters with record production and expanded magnet manufacturing, highlighting the intensifying race to secure a domestic supply chain for EVs and defense.

Jan 30, 2026

Business

AbbVie's Q4 Earnings in Focus: Can the Pharma Giant Sustain Its Growth Momentum?

All eyes are on AbbVie as it prepares to release its fourth-quarter earnings. With a history of topping revenue forecasts, the market watches to see if its strategic shifts can continue to deliver amid evolving industry pressures.

Feb 3, 2026

Business

Vera Therapeutics Bolsters Commercial Team with New CCO Ahead of Key Atacicept Decision

Vera Therapeutics appoints industry veteran Matt Skelton as Chief Commercial Officer, signaling a strategic pivot toward commercialization as its lead drug candidate for IgA nephropathy, atacicept, undergoes FDA Priority Review.

Feb 3, 2026

Business

Woodward Soars on Strong Q1, But Is the Aerospace Supplier's Rally Running Out of Fuel?

Aerospace and defense component maker Woodward, Inc. (WWD) is commanding investor attention following a robust first-quarter earnings beat, a significant dividend hike, and an upgraded full-year outlook. The strong results have propelled the stock to new highs, reigniting the debate over its valuation in a rapidly evolving industry.

Feb 3, 2026

Business

Vishay Intertechnology Set to Report Q4 Earnings Amid Sector Momentum

As Vishay Intertechnology prepares to release its fourth-quarter results, investors are weighing the chipmaker's recent performance against a backdrop of industry-wide gains and mixed signals from peers.

Feb 3, 2026

Business

Avery Dennison Set to Report Q4 Earnings Amid Mixed Industrial Sector Performance

The adhesive and materials giant is expected to post modest revenue growth as investors gauge its resilience against a backdrop of uneven results from packaging industry peers.

Feb 3, 2026

Business

Nurix Therapeutics Emerges as a Quiet Force in Cancer Treatment, Backed by Promising Data and Pharma Deals

Nurix Therapeutics, a clinical-stage biopharma company, is gaining attention for its novel protein degradation platform. With strong early data for its lead drug, key regulatory designations, and strategic partnerships with industry giants, the company is positioning itself to address unmet needs in multi-billion dollar oncology markets.

Feb 3, 2026

Business

Johnson Controls Stock Soars 62% in a Year: Is the Rally Justified or Overheated?

Shares of building technologies giant Johnson Controls International have surged over 60% in the past year, dramatically outperforming the broader market. As the stock hovers near $123, investors are grappling with a critical question: does the current price reflect the company's true value, or has momentum outpaced fundamentals? A deep dive into valuation metrics suggests caution may be warranted.

Feb 3, 2026

Business

C4 Therapeutics: Can Its Protein-Degrading Tech Ignite a Biotech Rally?

Amid a challenging market for biotech, C4 Therapeutics (NASDAQ: CCCC) is drawing investor attention with its targeted protein degradation platform. Backed by industry giants and focused on niche cancers, the clinical-stage company presents a high-risk, high-reward proposition. We examine the bull case and the road ahead.

Feb 3, 2026

Business

Privia Health's Capital-Light Model Positions It for Growth in Value-Based Care Shift

As the healthcare industry accelerates its shift to value-based care, Privia Health Group's physician-enablement platform is drawing investor attention for its scalable, asset-light approach and strong financial profile, with some analysts seeing significant upside potential.

Feb 3, 2026

Business

Acadia Healthcare: A Deep-Value Turnaround Play Attracting Activist Attention

Amidst legal overhangs and a depressed share price, behavioral health provider Acadia Healthcare is showing signs of a financial inflection point. With activist investors circling and free cash flow on the horizon, some analysts see a classic 'broken growth' story poised for recovery.

Feb 3, 2026

Business

Rent Revolution: Why Wall Street Is Betting Big on Single-Family Landlord Invitation Homes

As soaring home prices and mortgage rates lock out buyers, the single-family rental market is booming. Investment analysts are making a bullish case for industry leader Invitation Homes (INVH), citing its massive scale, near-full occupancy, and a dividend yield that looks attractive against a backdrop of resilient housing demand.

Feb 3, 2026

Business

IonQ Bets on Vertical Integration with Foundry and Networking Acquisitions

Quantum computing firm IonQ moves to acquire semiconductor foundry SkyWater Technology and optical communications specialist Skyloom Global, aiming to create the industry's first vertically integrated quantum company and gain tighter control over its core technology stack.

Feb 3, 2026

Business

Cirrus Logic's Valuation Under the Microscope: Is the Stock Running Ahead of Itself?

Cirrus Logic (CRUS) shares have surged over 31% in the past year, prompting investors to question whether the current price fully reflects the company's prospects. A deep dive into valuation metrics suggests the semiconductor stock may be trading at a significant premium.

Feb 2, 2026

Business

Musk's SpaceX and xAI to Merge in Landmark $1.25 Trillion Deal Ahead of Public Offering

Elon Musk is set to combine his aerospace giant SpaceX with his artificial intelligence venture xAI, creating a single entity valued at $1.25 trillion ahead of a highly anticipated IPO later this year, according to a Bloomberg report.

Feb 2, 2026

Business

Universal Pulls CFO Offer from ADM Executive Amid SEC Accounting Scandal

Universal has rescinded its employment offer to a former ADM finance executive just one day after the SEC filed suit against ADM's ex-CFO over alleged accounting misconduct in the nutrition segment, highlighting the widening fallout from the agribusiness giant's regulatory troubles.

Feb 2, 2026

Business

Oracle's $50 Billion AI Bet Sends Stock on a Rollercoaster Ride

Oracle's ambitious plan to raise up to $50 billion for AI infrastructure has triggered volatile swings in its share price, reflecting broader investor anxiety over the massive capital demands of the artificial intelligence arms race.

Feb 2, 2026

Business

Waymo's Robotaxi Premium Narrows as Autonomous Rideshare Market Heats Up

A new study reveals the cost gap between Waymo's driverless vehicles and human-driven Uber and Lyft rides is shrinking, signaling a pivotal moment for the competitive robotaxi industry.

Feb 2, 2026

Business

Reddit's Q4 Earnings: A Litmus Test for AI Ambitions and Premium Valuation

As Reddit prepares to report its fourth-quarter results on February 5th, investors are weighing its surging user growth and lucrative data-licensing deals against a sky-high valuation and a volatile market backdrop.

Feb 2, 2026